xuezhikang
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Atherosclerosis is a multifactorial vascular disease characterized by formation of inflammatory lesions. Secretory phospholipase…
Abstract Background: The aim of this study was to assess the preventive effect of xuezhikang (XZK) to replace atorvastatin on the…
Objective To assess the effectiveness of xuezhikang for treating diabetic kidney disease.Methods We searched the Cochrane Central…
OBJECTIVE
To evaluate the effect of Xuezhikang (XZK) on cardiac function and serum C-reactive protein (CRP) in patients with…
OBJECTIVE
To investigate whether xuezhikang has additional beneficial effect on lipid peroxidation, myocardial fibrosis…
OBJECTIVE
To evaluate whether lipid-lowering therapy with Xuezhikang can reduce the risk of cardiac events and total mortality in…
OBJECTIVE
To observe the intervention of Xuezhikang (XZK) on patients of acute coronary syndrome (ACS) with different levels of…
Objective:To compare the effects of xuezhikang and domestic simvastatin on the blood lipid profile in patients with…
OBJECTIVE
To study the effects of Xuezhikang on lipid profile, thromboxane (TX) A(2), prostacyclin (PGI(2)) in patients with…
Xuezhikang is a new blood-lipid-regulating medicine. The components of Xuezhikang include HMG-CoA reductase inhibitor (lovastatin…